Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 4/20 | 0.35 |
| ▸ | PKLR | P30613 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12412819 | 0.95 | PKM (0.33) | PKMPKLRRAB9AKDM4EMEN1 | |
| SCHEMBL12413088 | 0.95 | PKM (0.36) | PKMPKLRRAB9AKDM4EMEN1 | |
| SCHEMBL12412859 | 0.94 | PKM (0.36) | PKMPKLRRAB9AKDM4EMEN1 | |
| SCHEMBL12504748 | 0.90 | PKM (0.32) | PKMPKLRRAB9A | |
| SCHEMBL12412820 | 0.89 | PKM (0.34) | PKMPKLRRAB9AKDM4EMEN1 | |
| SCHEMBL12412900 | 0.89 | PKM (0.32) | PKMPKLRKDM4EMEN1KMT2A | |
| SCHEMBL12413078 | 0.87 | PKM (0.34) | PKMPKLRRAB9AKDM4EMEN1 | |
| SCHEMBL12413083 | 0.87 | PKM (0.37) | PKMPKLRRAB9AKDM4EMEN1 | |
| SCHEMBL12413095 | 0.86 | PKM (0.35) | PKMPKLRRAB9A | |
| SCHEMBL12413111 | 0.85 | HSD17B10 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166362-A1 | NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL | SCLY, MSRB3, SOD1 | PKM 4352/4885PKLR 3933/4885RAB9A 2655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.